AI Summary
Thinking
Thinking
We reviewed 3 live results for brca1 brca2 testing and narrowed them down to the 3 options that look most worth comparing first.
The options are BRCA1/BRCA2 A VISEE THERANOSTIQUE, Pressure Testing Unit and Genetic (BRCA1&2) Screening Test.
Source: Cerba lab
Description
L'examen BRCA1/BRCA2 à visée théranostique proposé par le laboratoire Cerba est un panel génétique réalisé par séquençage à haut débit NGS. Destiné à l'oncogénétique pour des cancers tels que le sein, l'ovaire, la prostate, le pancréas et l'endomètre, il analyse l'ADN à partir de sang total EDTA. Le délai moyen de rendu est de 60 jours pour un tarif hors nomenclature de 882,9 euros, nécessitant une prescription médicale spécialisée.
Best for
Médecins spécialistes, Oncologues, Orientation théranostique en oncologie and Recherche de mutations BRCA1 et BRCA2
Rate this product
Source: FRITZ EMDE
Description
The FRITZ EMDE HSP-F is a German-made mobile pressure testing unit and flexible, manually operated pump engineered for testing wall hydrants, risers, and pressure hoses for resting flow and pressure. Item numbered 488 000, it features an integrated 50-liter water collection tank with a quick-draining bottom ball valve, a maximum test and operating pressure of 16 bar, a 1.6-meter connection hose, and Storz-C and multi-standard coupling options.
Best for
fire safety inspectors, maintenance technicians, testing wall hydrants and risers and checking resting flow and pressure on hoses
Rate this product
Source: The Cancer Centre
Description
The Cancer Centre in Singapore provides Genetic (BRCA1 & BRCA2) Screening Tests to assess hereditary cancer risks, particularly for breast, ovarian, pancreatic, and prostate cancers. The screening helps identify inherited gene mutations that elevate cancer risk, enabling individuals with a family history or specific clinical indicators to pursue tailored medical management, enhanced surveillance like mammograms and MRIs, or preventive surgical interventions with specialist consultation.
Best for
Individuals with a family history of breast or ovarian cancer, Patients seeking proactive hereditary cancer risk assessment, Hereditary cancer risk screening and Preventive oncology planning
Rate this product
| Compare | #1BRCA1/BRCA2 A VISEE THERANOSTIQUE | #2Pressure Testing Unit | #3Genetic (BRCA1&2) Screening Test |
|---|---|---|---|
| Source | Cerba lab | FRITZ EMDE | The Cancer Centre |
| Description | L'examen BRCA1/BRCA2 à visée théranostique proposé par le laboratoire Cerba est un panel génétique réalisé par séquençage à haut débit NGS. Destiné à l'oncogénétique pour des cancers tels que le sein, l'ovaire, la prostate, le pancréas et l'endomètre, il analyse l'ADN à partir de sang total EDTA. Le délai moyen de rendu est de 60 jours pour un tarif hors nomenclature de 882,9 euros, nécessitant une prescription médicale spécialisée. | The FRITZ EMDE HSP-F is a German-made mobile pressure testing unit and flexible, manually operated pump engineered for testing wall hydrants, risers, and pressure hoses for resting flow and pressure. Item numbered 488 000, it features an integrated 50-liter water collection tank with a quick-draining bottom ball valve, a maximum test and operating pressure of 16 bar, a 1.6-meter connection hose, and Storz-C and multi-standard coupling options. | The Cancer Centre in Singapore provides Genetic (BRCA1 & BRCA2) Screening Tests to assess hereditary cancer risks, particularly for breast, ovarian, pancreatic, and prostate cancers. The screening helps identify inherited gene mutations that elevate cancer risk, enabling individuals with a family history or specific clinical indicators to pursue tailored medical management, enhanced surveillance like mammograms and MRIs, or preventive surgical interventions with specialist consultation. |
| Best for | Médecins spécialistes, Oncologues, Orientation théranostique en oncologie and Recherche de mutations BRCA1 et BRCA2 | fire safety inspectors, maintenance technicians, testing wall hydrants and risers and checking resting flow and pressure on hoses | Individuals with a family history of breast or ovarian cancer, Patients seeking proactive hereditary cancer risk assessment, Hereditary cancer risk screening and Preventive oncology planning |
| Action | Cerba lab | FRITZ EMDE | The Cancer Centre |
| Rate this product |
"BRCA1/BRCA2 A VISEE THERANOSTIQUE from Cerba lab."
Note: TopFind AI compiles product and service information for general comparison purposes only.